Rui‐Hua Xu

Publishes on Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers. 1.4k papers and 54.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#8 Current Senior Leader in Gastric Cancer Management and Outcomes

1.4kPublications

54.6kTotal Citations

#8in Gastric Cancer Management and Outcomes

First publication: 1992First senior author: 2007

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers Esophageal Cancer Research and Treatment RNA modifications and cancer

Top publicationsby citations

Circular RNA: metabolism, functions and interactions with proteins

Zhou Wei-yi, Rui‐Hua Xu|Molecular Cancer|2020

Cited by 1.6k

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

Ting Li, Rui‐Hua Xu|Molecular Cancer|2019

Cited by 868

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

Kohei Shitara, Jaffer A. Ajani, Florian Lordick et al.|The Lancet|2023

Cited by 701

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

Feng‐Hua Wang, Rui‐Hua Xu, Xiao‐Tian Zhang et al.|Cancer Communications|2021

Cited by 657

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Jean‐Yves Douillard, Dirk Arnold et al.|Annals of Oncology|2017

Cited by 591